SEC Form 8-K Summary
Business Context and Reporting Period
The filing was submitted by Coeptis Therapeutics Holdings, Inc., not Z Squared Inc., and reports an event dated June 5, 2023. Coeptis stated that it began using an investor presentation in discussions with investors and analysts. The company’s common stock and warrants traded on the Nasdaq Global Market under symbols COEP and COEPW, respectively.
Financial Metrics and Liquidity
This Form 8-K does not provide revenue, profit or loss, cash flow, margins, debt, liquidity, or other operating metrics. The text identifies an investor presentation as Exhibit 99.1, but the presentation’s substantive contents are not included in the supplied filing text.
Material Changes Versus Prior Period
No financial or operational changes versus a prior comparable period are disclosed in the supplied text.
Guidance, Outlook, Risks, and Unusual Items
- The investor presentation was intended for use in current and future investor and analyst presentations.
- The company stated that the information was presented as of June 5, 2023 and assumed no obligation to update it.
- Coeptis cautioned that furnishing the presentation did not mean the information was material or complete, or that investors should consider it before making an investment decision.
- The disclosure under Item 7.01 was furnished, rather than filed for purposes of Section 18 of the Exchange Act, and was not incorporated by reference into other filings unless expressly stated.
- The filing does not provide specific guidance, forecasts, contingencies, or risk-factor updates.
Investor Verification Checklist
- Verify the issuer identity: the supplied filing names Coeptis Therapeutics Holdings, Inc., while the request metadata identifies Z Squared Inc.
- Review Exhibit 99.1 for the presentation’s business strategy, pipeline, financial information, projections, and risk disclosures; those details are not present in the supplied text.
- Confirm whether any statements in the presentation constitute forward-looking information and assess the stated limitations on updating the materials.
- Consult the company’s periodic reports for current financial condition, liquidity, capital requirements, debt, and operating results.